Results 241 to 250 of about 9,276,761 (294)
Some of the next articles are maybe not open access.
International Journal of Peptide and Protein Research, 1987
Neuropeptide Y (NPY), a hexatriacontapeptide amide, was synthesized on benzhydrylamine resin. The peptide product obtained by HF treatment contained 63% of the target peptide, NPY. A comparison of the chemical, immuno‐chemical and biological properties of the synthetic peptide with natural NPY indicated that they were identical.
Josef E. Fischer +6 more
openaire +2 more sources
Neuropeptide Y (NPY), a hexatriacontapeptide amide, was synthesized on benzhydrylamine resin. The peptide product obtained by HF treatment contained 63% of the target peptide, NPY. A comparison of the chemical, immuno‐chemical and biological properties of the synthetic peptide with natural NPY indicated that they were identical.
Josef E. Fischer +6 more
openaire +2 more sources
Nutrition, 2008
Cachexia or wasting disease occurs commonly in diseases that have an overproduction of proinflammatory cytokines associated with them. The hallmarks of cachexia are loss of lean and adipose tissue, anorexia, anemia, memory disturbance, and sickness behavior.
Morley, J., Farr, S.
openaire +4 more sources
Cachexia or wasting disease occurs commonly in diseases that have an overproduction of proinflammatory cytokines associated with them. The hallmarks of cachexia are loss of lean and adipose tissue, anorexia, anemia, memory disturbance, and sickness behavior.
Morley, J., Farr, S.
openaire +4 more sources
Sleep Medicine Reviews, 2010
Neuropeptide Y (NPY), a 36-amino-acid peptide from the pancreatic polypeptide family, is one of the more abundant peptides in the central nervous system. It acts as a neurohormone and as a neuromodulator. NPY is widely distributed in the brain, particularly the hypothalamus, the amygdala, the locus coeruleus and the cerebral cortex.
Dyzma, Michal +3 more
openaire +3 more sources
Neuropeptide Y (NPY), a 36-amino-acid peptide from the pancreatic polypeptide family, is one of the more abundant peptides in the central nervous system. It acts as a neurohormone and as a neuromodulator. NPY is widely distributed in the brain, particularly the hypothalamus, the amygdala, the locus coeruleus and the cerebral cortex.
Dyzma, Michal +3 more
openaire +3 more sources
The role of neuropeptide Y and peptide YY in the development of obesity via gut-brain axis.
Current protein and peptide science, 2019Obesity is one of the main challenges of public health in the 21st century. Obesity can induce a series of chronic metabolic diseases, such as diabetes, dyslipidemia, hypertension and nonalcoholic fatty liver, which seriously affect human health.
Yi Wu +4 more
semanticscholar +1 more source
Radioimmunoassay of neuropeptide Y
Regulatory Peptides, 1984The development of a radioimmunoassay to the newly isolated peptide, neuropeptide Y is described. Four separate antisera have been developed using different immunisation schedules. Two of these antisera (YNI and YNIO) are directed to the C-terminal region of the peptide and cross-react with the related peptide PYY, whereas YN7 is specific being ...
J.C. Yeats +3 more
openaire +3 more sources
Neuropeptide Y: A putative neurotransmitter
Neurochemistry International, 1986Since its isolation in 1982, neuropeptide Y (NPY) has received considerable interest. This 36 amino acid peptide has been identified widely throughout the central and peripheral nervous systems, and within the autonomic system it appears in close association but not exclusively within catecholamine containing nerves.
C. Maccarrone, Bevyn Jarrott
openaire +4 more sources
2016
Neuropeptide Y (NPY) was first purified and isolation from porcine brain in 1982, and consists of 36 amino acids. NPY is distributed in the brain, sympathetic nervous system, and adrenal gland. Five distinct NPY receptors have been cloned, namely Y1, Y2, Y4, Y5, and y6, as seven transmembrane G (Gi and G0) protein-coupled receptors.
Goro Katsuura, Akio Inui
openaire +2 more sources
Neuropeptide Y (NPY) was first purified and isolation from porcine brain in 1982, and consists of 36 amino acids. NPY is distributed in the brain, sympathetic nervous system, and adrenal gland. Five distinct NPY receptors have been cloned, namely Y1, Y2, Y4, Y5, and y6, as seven transmembrane G (Gi and G0) protein-coupled receptors.
Goro Katsuura, Akio Inui
openaire +2 more sources
Quantitative microdialysis of neuropeptide Y
Journal of Neuroscience Methods, 1995The feasibility of using the difference method of quantitative microdialysis to measure neuropeptide Y (NPY) was evaluated in vitro and in vivo. The accuracy of this method was tested in vitro under steady-state conditions for 3 test solutions containing known concentrations of NPY. The estimated concentrations of NPY were 1.2 +/- 0.6, 3.7 +/- 0.9, and
John K. McDonald +2 more
openaire +3 more sources
Microcirculatory Dynamics of Neuropeptide Y
Microvascular Research, 1994We used the hamster cheek pouch microcirculation to investigate by intravital microscopy the effects of neuropeptide Y (NPY) on arteriolar diameter, leukocyte adhesion to microvascular endothelium, and postcapillary venular permeability. We applied NPY topically for 3 min at concentrations of 10(-7), 10(-9), and 10(-11) M.
Walter T.R. Durán +4 more
openaire +3 more sources